clinical trial · NCT06100939
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
KeratoconusRiboflavin and Sodium Iodide solution and Ultraviolet-A treatmentPlacebo and sham treatment
brief summary
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
started
Oct 30, 2023
primary completion
Oct 1, 2025
completion
Oct 1, 2025
last updated
May 1, 2025
official title
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus (APRICITY-A)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol